Mutation of Position 52 in ERK2 Creates a Nonproductive Binding Mode for Adenosine 5‘-Triphosphate,
The DOI matches its Crossref record.
Abstract
Among the protein kinases, an absolutely conserved lysine in subdomain II is required for high catalytic activity. This lysine is known to interact with the substrate ATP, but otherwise its role is not well understood. We have used biochemical and structural methods to investigate the function of this lysine (K52) in phosphoryl transfer reactions catalyzed by the MAP kinase ERK2. The kinetic properties of activated wild-type ERK2 and K52 mutants were examined using the oncoprotein TAL2, myelin basic protein, and a designed synthetic peptide as substrates. The catalytic activities of K52R and K52A ERK2 were lower than that of wild-type ERK2, primarily as a consequence of reductions in kcat. Further, there was little difference in Km for ATP, but the Km,app for peptide substrate was higher for the K52 mutants. The three-dimensional structure of unphosphorylated K52R ERK2 in the absence and presence of bound ATP was determined and compared with the structure of unphosphorylated wild-type ERK2. ATP adopted a well-defined but distinct binding mode in K52R ERK2 compared to the binding mode in the wild-type enzyme. The structural and kinetic data show that mutation of K52 created a nonproductive binding mode for ATP and suggest that K52 is essential for orienting ATP for catalysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034
Self-citationKrishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
Synthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535
Activation mechanism of the MAP kinase ERK2 by dual phosphorylation
Canagarajah, B. J., Khokhlatchev, A., Cobb, M. H., & Goldsmith, E. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80351-7 · Cited by 729
Self-citationKinetic and Catalytic Mechanisms of Protein Kinases
Adams, J. A. (2001) · Chemical Reviews · doi:10.1021/cr000230w · Cited by 627
Pyridinyl Imidazole Inhibitors of p38 Mitogen-activated Protein Kinase Bind in the ATP Site
Young, P. R., McLaughlin, M. M., Kumar, S., Kassis, S., Doyle, M. L., McNulty, D., Gallagher, T. F., Fisher, S., McDonnell, P. C., Carr, S. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12116 · Cited by 570
WNK1, a Novel Mammalian Serine/Threonine Protein Kinase Lacking the Catalytic Lysine in Subdomain II
Xu, B.-E., English, J. M., Wilsbacher, J. L., Stippec, S., Goldsmith, E. J., & Cobb, M. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.22.16795 · Cited by 538
Self-citationNew Insights into the Control of MAP Kinase Pathways
English, J., Pearson, G., Wilsbacher, J., Swantek, J., Karandikar, M., Xu, S., & Cobb, M. H. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4687 · Cited by 434
Self-citationCa2+/Calmodulin-dependent Protein Kinases
Swulius, M. T., & Waxham, M. N. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8086-2 · Cited by 396
Hu, S., Xie, Z., Onishi, A., Yu, X., Jiang, L., Lin, J., Rho, H.-S., Woodard, C., Wang, H., Jeong, J.-S., et al. (2009) · Cell · doi:10.1016/j.cell.2009.08.037 · Cited by 383
Structures of Src-family tyrosine kinases
Sicheri, F., & Kuriyan, J. (1997) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(97)80146-7 · Cited by 380
Robinson, M. J., Stippec, S. A., Goldsmith, E., White, M. A., & Cobb, M. H. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00485-x · Cited by 311
Self-citationCatalytic Control in the EGF Receptor and Its Connection to General Kinase Regulatory Mechanisms
Jura, N., Zhang, X., Endres, N. F., Seeliger, M. A., Schindler, T., & Kuriyan, J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.004 · Cited by 310
“This lysine residue is commonly mutated to generate inactive forms of kinase domains (Robinson et al., 1996).”
BackgroundRequirement for PAK4 in the Anchorage-independent Growth of Human Cancer Cell Lines
Callow, M. G., Clairvoyant, F., Zhu, S., Schryver, B., Whyte, D. B., Bischoff, J. R., Jallal, B., & Smeal, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105732200 · Cited by 288
Samuels, I. S., Karlo, J. C., Faruzzi, A. N., Pickering, K., Herrup, K., Sweatt, J. D., Saitta, S. C., & Landreth, G. E. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0679-08.2008 · Cited by 278
Yamaguchi, H., Matsushita, M., Nairn, A. C., & Kuriyan, J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00256-8 · Cited by 278
Structural and Functional Diversity of the Microbial Kinome
Kannan, N., Taylor, S. S., Zhai, Y., Venter, J. C., & Manning, G. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050017 · Cited by 264
A Novel MAP Kinase Regulates Flagellar Length in Chlamydomonas
Berman, S. A., Wilson, N. F., Haas, N. A., & Lefebvre, P. A. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00415-9 · Cited by 208
An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors
Seidel, J. J., & Graves, B. J. (2002) · Genes & Development · doi:10.1101/gad.950902 · Cited by 182
The Role of Extracellular Regulated Kinases I/II in Late-Phase Long-Term Potentiation
Rosenblum, K., Futter, M., Voss, K., Erent, M., Skehel, P. A., French, P., Obosi, L., Jones, M. W., & Bliss, T. V. P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05432.2002 · Cited by 155
“A second mutant EGFP-ERKII protein (“kinase-dead mutant”) was generated by replacing lysine-52 by alanine, thus preventing the binding of ATP and rendering the protein kinase domain inactive (Robinson et al., 1996) (Fig.”
MethodIñiguez, S. D., Vialou, V., Warren, B. L., Cao, J.-L., Alcantara, L. F., Davis, L. C., Manojlovic, Z., Neve, R. L., Russo, S. J., Han, M.-H., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0951-10.2010 · Cited by 103
Carrier, N., & Kabbaj, M. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.028 · Cited by 84
Mae inhibits Pointed‐P2 transcriptional activity by blocking its MAPK docking site
Qiao, F., Harada, B., Song, H., Whitelegge, J., Courey, A. J., & Bowie, J. U. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600924 · Cited by 41
Molecular Determinants of Substrate Recognition in Hematopoietic Protein-tyrosine Phosphatase
Huang, Z., Zhou, B., & Zhang, Z.-Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407820200 · Cited by 23
Crowe, M. S., Zavorotinskaya, T., Voliva, C. F., Shirley, M. D., Wang, Y., Ruddy, D. A., Rakiec, D. P., Engelman, J. A., Stuart, D. D., & Freeman, A. K. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-1022 · Cited by 6
Metadata
- Authors
- Robinson, M. J., Harkins, P. C., Zhang, J., Baer, R., Haycock, J. W., Cobb, M. H., & Goldsmith, E. J.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1996-01-01
- Volume
- 35
- Issue
- 18
- Pages
- 5641-5646
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2092961902
- Cited by
- 136
- References
- 0
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.